Fatigue, depression, and product tolerability during long-term treatment with intravenous immunoglobulin (Gamunex® 10%) in patients with chronic inflammatory demyelinating polyneuropathy

被引：0
|
作者：
Juliane Klehmet
Björn Tackenberg
Judith Haas
Bernd C. Kieseier
机构：
[1] Charité - Universitätsmedizin Berlin,Klinik Fur Neurologie
[2] Neurocure Clinical Research Center Berlin,undefined
[3] Jüdisches Krankenhaus Berlin,undefined
[4] Klinik Und Poliklinik Für Neurologie,undefined
[5] Heinrich-Heine Universität,undefined
来源：
BMC Neurology | / 23卷
关键词：
CIDP; IVIG; Real-world evidence; Patient-reported outcome measures; Quality of life;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 36 条
  • [21] Short-term and long-term effects of immunoadsorption in refractory chronic inflammatory demyelinating polyneuropathy: a prospective study in 17 patients
    Johannes Dorst
    Albert C. Ludolph
    Makbule Senel
    Hayrettin Tumani
    Journal of Neurology, 2018, 265 : 2906 - 2915
  • [22] Intravenous Immunoglobulin Treatment Patterns and Outcomes in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims Database Analysis
    Colin Anderson-Smits
    Mary E. Ritchey
    Zhongwen Huang
    Shailesh Chavan
    Nizar Souayah
    Hakan Ay
    J. Bradley Layton
    Neurology and Therapy, 2023, 12 : 1119 - 1132
  • [23] Intravenous Immunoglobulin Treatment Patterns and Outcomes in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims Database Analysis
    Anderson-Smits, Colin
    Ritchey, Mary E. E.
    Huang, Zhongwen
    Chavan, Shailesh
    Souayah, Nizar
    Ay, Hakan
    Layton, J. Bradley
    NEUROLOGY AND THERAPY, 2023, 12 (04) : 1119 - 1132
  • [24] Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra study
    Mielke, Orell
    Bril, Vera
    Cornblath, David R.
    Lawo, John-Philip
    van Geloven, Nan
    Hartung, Hans-Peter
    Lewis, Richard A.
    Merkies, Ingemar S. J.
    Sobue, Gen
    Durn, Billie
    Shebl, Amgad
    van Schaik, Ivo N.
    Sabet, A.
    George, K.
    Roberts, L.
    Carne, R.
    Blum, S.
    Henderson, R.
    Van Damme, P.
    Demeestere, J.
    Larue, S.
    D'Amour, C.
    Kunc, P.
    Valis, M.
    Sussova, J.
    Kalous, T.
    Talab, R.
    Bednar, M.
    Toomsoo, T.
    Rubanovits, I.
    Gross-Paju, K.
    Sorro, U.
    Saarela, M.
    Auranen, M.
    Pouget, J.
    Attarian, S.
    Le Masson, G.
    Wielanek-Bachelet, A.
    Desnuelle, C.
    Delmont, E.
    Clavelou, P.
    Aufauvre, D.
    Schmidt, J.
    Zschuentzsch, J.
    Sommer, C.
    Kramer, D.
    Hoffmann, O.
    Goerlitz, C.
    Haas, J.
    Chatzopoulos, M.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2019, 24 (01) : 72 - 79
  • [25] Long-term treatment with subcutaneous immunoglobulin in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a follow-up period up to 7 years
    Gentile, L.
    Mazzeo, A.
    Russo, M.
    Arimatea, I
    Vita, G.
    Toscano, A.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [26] PROGNOSIS IN LONG-TERM IMMUNOSUPPRESSIVE TREATMENT OF REFRACTORY CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY
    BROMBERG, MB
    FELDMAN, EL
    JARADEH, S
    ALBERS, JW
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (01) : 47 - 52
  • [27] Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy
    Dyer, Wayne B.
    Tan, Joanne C. G.
    Day, Timothy
    Kiers, Lynette
    Kiernan, Matthew C.
    Yiannikas, Con
    Reddel, Stephen
    Ng, Karl
    Mondy, Phillip
    Dennington, Peta M.
    Dean, Melinda M.
    Trist, Halina M.
    dos Remedios, Cristobal
    Hogarth, P. Mark
    Vucic, Steve
    Irving, David O.
    BRAIN AND BEHAVIOR, 2016, 6 (10):
  • [28] Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy - A double-blind, placebo-controlled, cross-over study
    Hahn, AF
    Bolton, CF
    Zochodne, D
    Feasby, TE
    BRAIN, 1996, 119 : 1067 - 1077
  • [29] A Budget Impact Model of Maintenance Treatment of Chronic Inflammatory Demyelinating Polyneuropathy with IgPro20 (Hizentra) Relative to Intravenous Immunoglobulin in the United States
    Mallick, Rajiv
    Carlton, Rashad
    Van Stiphout, Joris
    PHARMACOECONOMICS-OPEN, 2023, 7 (02) : 243 - 255
  • [30] Subcutaneous immunoglobulin as first-line therapy in treatment-naive patients with chronic inflammatory demyelinating polyneuropathy: randomized controlled trial study
    Markvardsen, L. H.
    Sindrup, S. H.
    Christiansen, I.
    Olsen, N. K.
    Jakobsen, J.
    Andersen, H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 (02) : 412 - 418
1234